Veradermics stock surges 17% on positive hair loss trial data
Investing.com Gold reports: Veradermics stock surges 17% on positive hair loss trial data. Full body text was unavailable at ingest time, so this brief is based on headline context.
Investing.com Gold reports: Veradermics stock surges 17% on positive hair loss trial data. Full body text was unavailable at ingest time, so this brief is based on headline context.